Long-term anabolic steroid use could weaken arteries

New research from Massachusetts General Hospital shows that long-term anabolic steroid use could harm the heart and eventually cause coronary artery disease.

The long-term effects of using these drugs are just now emerging since they became widely used in the 1980s, according to the study, launched by Aaron Baggish, MD, the associate director of the cardiovascular performance program at Massachusetts General in Boston.

The observational study included 140 male weightlifters, 86 of whom used anabolic steroids and 54 who did not. Of the users, 58 were using the drugs and 28 were not during evaluations. Those who used the steroids showed higher body and fat-free mass indexes, which is consistent with the effects of anabolic steroids. The findings were published in Circulation.

To test how the steroids affected the onset of coronary artery disease, Baggish’s team used 2D ultrasound imaging. Results showed that the left ventricle was significantly weaker during contraction in patients who took anabolic steroids compared to those who didn’t. Diastolic function was also impaired for steroid users.

“Compared to non-users, anabolic steroid users displayed both higher systolic and diastolic blood pressure as well as a higher prevalence of levels of bad cholesterol in their blood,” Baggish said in a statement.

Katherine Davis,

Senior Writer

As a Senior Writer for TriMed Media Group, Katherine primarily focuses on producing news stories, Q&As and features for Cardiovascular Business. She reports on several facets of the cardiology industry, including emerging technology, new clinical trials and findings, and quality initiatives among providers. She is based out of TriMed's Chicago office and holds a bachelor's degree in journalism from Columbia College Chicago. Her work has appeared in Modern Healthcare, Crain's Chicago Business and The Detroit News. She joined TriMed in 2016.

Around the web

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."